Selective inhibition of human brain tumor cells through multifunctional quantum-dot-based siRNA delivery.
Jung
Jongjin
J
Department of Chemistry and Chemical Biology, Rutgers University, Piscataway, NJ 08854, USA.
Solanki
Aniruddh
A
Memoli
Kevin A
KA
Kamei
Ken-ichiro
K
Kim
Hiyun
H
Drahl
Michael A
MA
Williams
Lawrence J
LJ
Tseng
Hsian-Rong
HR
Lee
KiBum
K
D017209:Apoptosis; D001932:Brain Neoplasms / Q000378:metabolism / Q000628:therapy*; D045744:Cell Line, Tumor; D066246:ErbB Receptors / Q000235:genetics / Q000378:metabolism; D055785:Gene Knockdown Techniques; D006801:Humans; D009842:Oligopeptides / Q000737:chemistry / Q000378:metabolism; D019869:Phosphatidylinositol 3-Kinases / Q000378:metabolism; D051057:Proto-Oncogene Proteins c-akt / Q000378:metabolism; D045663:Quantum Dots; D034622:RNA Interference; D034741:RNA, Small Interfering / Q000378:metabolism*; D015398:Signal Transduction; D054322:tat Gene Products, Human Immunodeficiency Virus / Q000737:chemistry / Q000378:metabolism
D009842:Oligopeptides; D034741:RNA, Small Interfering; C410723:epidermal growth factor receptor VIII; D054322:tat Gene Products, Human Immunodeficiency Virus; C047981:arginyl-glycyl-aspartic acid; D019869:Phosphatidylinositol 3-Kinases; D066246:ErbB Receptors; D051057:Proto-Oncogene Proteins c-akt